Effects of a beta-blocker and spironolactone on plasma homocysteine levels.
Korkmaz
Mehmet E
ME
Atar
Ilyas
I
Tayfun
Egemen
E
Yildirir
Aylin
A
Ulucam
Melek
M
Ozin
Bülent
B
Muderrisoglu
Haldun
H
Turan
Munire
M
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000097:blood* / Q000517:prevention & control*; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects*; D006801:Humans; D008790:Metoprolol / Q000494:pharmacology* / Q000627:therapeutic use*; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000451:Mineralocorticoid Receptor Antagonists; D006710:Homocysteine; D013148:Spironolactone; D008790:Metoprolol